Global scar treatment market was valued at USD 12.3 Billion in 2020. It is projected to grow at a compound annual rate of 10.1% between 2021 and 2028. This market is driven primarily by an increasing demand for skin rejuvenation and aesthetic enhancements. The majority of demand is from women, who are more conscious about their appearance. Cosmetic procedures have seen a significant increase in demand due to the increasing number of burn injuries and road accidents. Globally, there has been an increase in hypertrophic burn scars, which are characterized by a victim's appearance becoming distorted.
The rapid adoption of telemedicine across all healthcare sectors marked the first two waves in the COVID-19 pandemic. Non-emergency skincare requires minimal hospitalizations. Although final procedures do require patients to visit the hospital, telemedicine is a preferred method of pre-planning and postprocedure management. Although COVID-19 has temporarily slowed the market growth in 2020's, the trends in telemedicine will play an important role in optimizing market growth compared to noncovid situations. The market will also grow in both developed and developing countries if more ambulatory surgery centers are established.
Scar treatment products are in high demand due to the rising number of road accidents. Population Reference Bureau estimates that around 50 million people are hurt in road accidents each year. This often leads to scarring, which requires surgical treatment. Patients who have undergone such procedures often develop scarring and are given topical products to enhance and reduce their appearance. The rising number of road accidents and the increase in cosmetic surgeries will likely drive the demand for topical scar treatments.
Plastic Surgery Statistics Report reports that 181,132 scar revisions were performed in 2019. This makes it one of the most popular reconstruction procedures. The demand for aesthetic appeal is a major factor in the increase in scar revision cases. Scar treatment products, in addition to corrective skin surgeries, are widely used.
The largest share, 58.0%, was held by topical products in 2020. Individuals can use them to treat scarring thanks to the availability of OTC products such as creams, gels and sheets. Because they are non-invasive, painless and do not cause any discomfort, laser products are widely used.
Topical products can be applied directly to the skin's surface. These products can be divided into creams and gels as well as silicone sheets. These products are easy to find and are often purchased because they are OTC. These products are also easy to use and do not require patients to see a physician for medication. This will increase the demand for these products.
Pressure garments include elastic bandages, oils sprays and ointments. For scarring treatment, pressure garments are applied to the area. These non-invasive treatments can be easily applied at home with no need for a doctor's consultation. These topical products may not be as effective and will require continued use for 6-12 months. This could limit the growth of the segment during the forecast period.
Due to rising acne scarring, trophic scars accounted for 36.4% of the total in 2020. These scars can be treated with creams or gels. Due to the frequent occurrence of hypertrophic and Keloid scars in people with wound injuries, they are expected to grow significantly over the forecast period.
Atrophic scars usually result from muscle and fat loss over the injured area. Atrophic scars occur when the skin does not produce enough collagen to heal the wound. This scar looks like a pit. It is often caused by acne, staphylococcus infection, chickenpox and, in rare cases, surgery.
These scars can be treated with creams, gels, or ointments, which are easily available and topical. These scars can be treated with creams, gels, or ointments that stimulate the skin's natural healing process and replace elastin, collain, and other fibrous tissue. This allows the skin to heal and grow around the affected area. These creams can reduce the visibility of scars due to acne. These creams are becoming more popular due to their aesthetic appeal.
With a market share of 43.0%, the hospitals segment was the dominant segment in 2020. This is due to the use of advanced infrastructure and the presence technologically advanced products in these settings. The retail pharmacies/e-commerce segment is projected to witness the fastest growth over the forecast period due to the rapid growth of online websites and easy access to scar treatment products on these websites. The growth of the HTML3_ e-commerce HTML3_ segment is expected to be boosted by the COVID-19 outbreak.
Hospitals offer the majority of scar treatments. Patients can choose from a variety of options to reduce and remove scarring. In most cases, hospitals provide emergency care, which can include treatment for severe injuries such as burns, cuts, or wounds. Hospitals also provide treatment, with the aim of reducing scarring. Large hospitals often have a variety of advanced equipment and procedures to provide patient care. Hospitals are equipped with noninvasive treatments such as creams and gels, as well as laser therapy.
Hospitals provide generalized care for most emergencies and care during recovery. Specialized attention is provided to burn victims to aid in the healing process. The majority of the world's population receives basic care at hospitals. This is why they hold the largest market share.
North America was the dominant market, with a 35.2% revenue share in 2020. This is due to high aesthetic consciousness and rapid adoption of advanced products. A number of advanced laser instruments are also in demand in America for scar treatment.
In 2020, the U.S. accounted for the largest market share in North America. The American Burn Association (ABA) estimates that there are 486,000 cases of burns annually. The U.S. government reimburses for scar treatment of burn injuries. However, scar treatment for acne is not covered unless a letter of medical necessity is issued by a healthcare professional. The U.S. market is also being driven by increased healthcare spending by patients. The U.S. scar treatment market is expected to grow due to these factors. The major players in the U.S. scar treatment market include Scar Heal, Inc., Cynosure, Inc., CCA Industries, Inc., and Cynosure, Inc.
Asia Pacific will see the highest CAGR at 11.4% during the forecast period. This is due to high road accident rates in India. India and China are the two largest countries in Asia Pacific. Most countries in the region are developing economies that are moving faster to adopt technological advances. The region's industries have been influenced by the increasing investment of multinational corporations in R&D. The market is expected to grow due to the significant increase in women's concern about aesthetic appeal.
To expand their scar treatment product lines, the market leaders are creating strategic alliances. Molnlycke Healthcare, for example, opened a Northamptonshire distribution center in December 2020. The new distribution center was designed to provide uninterrupted product supply in the U.K. despite uncertainty due to Brexit and COVID-19. The following are some of the major players in the global scar management market:
Smith & Nephew PLC
Lumenis
Merz Pharmaceuticals, LLC
Sonoma Pharmaceuticals, Inc.
Cynosure
CCA Industries, Inc.
Newmedical Technology Inc.
Molnlycke Health Care AB
Suneva Medical
Up Market Research published a new report titled “Scar Treatment Market research report which is segmented by Scar Type (Atrophic, Hypertrophic & Keloid Scars), by Product (Laser Products, Topical Products), By Players/Companies Sonoma Pharmaceuticals Inc, Suneva Medical, M¶lnlycke Health Care AB, CCA Industries Inc, Lumenis, Merz Pharmaceuticals LLC, Newmedical Technology Inc, Cynosure, Smith & Nephew PLC”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Attributes | Report Details |
Report Title | Scar Treatment Market Research Report |
By Scar Type | Atrophic, Hypertrophic & Keloid Scars |
By Product | Laser Products, Topical Products |
By Companies | Sonoma Pharmaceuticals Inc, Suneva Medical, M¶lnlycke Health Care AB, CCA Industries Inc, Lumenis, Merz Pharmaceuticals LLC, Newmedical Technology Inc, Cynosure, Smith & Nephew PLC |
Regions Covered | North America, Europe, APAC, Latin America, MEA |
Base Year | 2020 |
Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
Forecast Year | 2028 |
Number of Pages | 228 |
Number of Tables & Figures | 160 |
Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by Scar Type (Atrophic, Hypertrophic & Keloid Scars), by Product (Laser Products, Topical Products).
Scar Treatment Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the Scar Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the Scar Treatment Market Report:
Some other reports from this category!